EUVIMEDEUVIMED entdecken
Crossref

In Brief: Extended Duration of Use for Nexplanon

The Medical Letter on Drugs and Therapeutics · 02.03.2026 · 68 (1749) · 40-40

DOI: 10.58347/tml.2026.1749b ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, online erschienen am 02.03.2026.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nexplanon, a single-rod contraceptive implant containing the progestin etonogestrel, has now been approved for prevention of pregnancy for up to 5 years. It was previously approved for up to 3 years of use.

Schlagwörter

Stichwörter der Autor:innen

Nexplanoncontraceptivesefficacyetonogestrel

Zitieren

APA

(2026). In Brief: Extended Duration of Use for Nexplanon. The Medical Letter on Drugs and Therapeutics, 68(1749), 40-40. https://doi.org/10.58347/tml.2026.1749b

Vancouver

In Brief: Extended Duration of Use for Nexplanon. The Medical Letter on Drugs and Therapeutics. 2026;68(1749):40-40. doi:10.58347/tml.2026.1749b

BibTeX
@article{euvimed2026,
  title = {In Brief: Extended Duration of Use for Nexplanon},
  journal = {The Medical Letter on Drugs and Therapeutics},
  year = {2026},
  volume = {68},
  number = {1749},
  pages = {40--40},
  doi = {10.58347/tml.2026.1749b}
}
Kostenlos starten →